Davy Defensive Equity Income D EUR Acc

Ranked 78 out of 86 in - Global Equity Income over 36 months
All calculations are in GBP unless stated

Managed by

Jonathan Linnane

Mark Seavers

Mark Seavers is the chief investment officer of Davy Asset Management. Mark has over 28 years' investment experience in a range of asset classes. He is the chairperson of the Davy Asset Management Asset Allocation Committee and is responsible for co-ordinating and overseeing the investment teams and strategies. Mark is also the lead fund manager for Davy Asset Management's suite of Global Equity Income products. Mark joined Davy Asset Management in 2014, when Davy Asset Management acquired Prescient Investment Managers (previously Allied Irish Bank Investment Managers, AIBIM). Mark began his investment career in 1988 at AIBIM and was appointed to the portfolio management team in 1992. Mark holds a Master of Arts in Economics and a Master of Finance from University College Dublin.

Objective

To provide investors with long term capital growth, with reduced levels of volatility compared to global equity markets. The Fund will also seek to deliver stable returns through investments in certain securities that provide steady dividend returns. The Fund does this by investing in large global companies that pay out above average dividend yields compared to other companies in their sector. The Fund employs an investment policy which provides for some downside protection against significant market falls.

Showing fund performance in United Kingdom View performance globally

Performance

Global Equity Income over : 31/05/2016 - 31/05/2019

Total Return

Quarterly Performance

to 31/03/2019 Annual Q1 Q2 Q3 Q4
2019 5.0%
2018 -2.5% -6.6% 4.3% 5.0% -4.7%
2017 1.5% 1.0% -1.0% -0.6% 2.1%
2016 23.3% 3.7% 8.8% 3.5% 5.6%
2015 1.4% 3.9% -6.5% -1.2% 5.6%
2014 5.3% -1.2% 0.0% 2.8% 3.7%
2013 -2.3% 1.3%

Month by Month Performance

Returns Vs Risk

Asset Allocation

Breakdown

30/04/2019

Top 10 Holdings

Stock Size
EUR Cash 10.27%
Microsoft Corp ORD 4.57%
JPMorgan Chase & Co ORD 3.64%
Johnson & Johnson ORD 3.03%
Merck & Co Inc ORD 2.79%
Pfizer Inc ORD 2.63%
Procter & Gamble Co ORD 2.52%
Nestle SA ORD 2.39%
Public Service Enterprise Group Inc ORD 2.34%
Verizon Communications Inc ORD 2.22%
30/04/2019

Registered For Sale In

  1. Austria
  2. Ireland
  3. United Kingdom

Fund Info

  • Launch date22/07/2015
  • Share Class size00Mn
  • Base currencyEUR
  • ISIN IE00BX7RQ625

Purchase Info

  • Min. initial investment25,000
  • Min. regular additional investment0

Charges

  • Annual management0.68%

Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated).